Welcome to our dedicated page for ALTIGEN COMMUNS news (Ticker: $ATGN), a resource for investors and traders seeking the latest updates and insights on ALTIGEN COMMUNS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ALTIGEN COMMUNS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ALTIGEN COMMUNS's position in the market.
Altigen Technologies reported its second-quarter results for fiscal year 2024, showing an increase in net revenue to $3.4 million and a gross margin of 61.3%. The GAAP net loss was ($0.2) million, while non-GAAP net loss was ($0.07) million. Altigen's President & CEO, Jeremiah Fleming, highlighted the progress in business transformation and expense reduction.